The New York Times @nytimes
The New York Times interviewed more than 40 patients who said their access to ketamine, a psychedelic-like drug, expanded through telehealth. Many said it was life-changing, but some described serious drawbacks that are largely played down by proponents. https://t.co/PGthbFL6bL — PolitiTweet.org